The drug "Memoplant" is a herbal remedy. The active ingredient is biloba ginkgo leaf dry extract.
Despite the fact that the mechanism of the effect of the drug has not been fully studied, many experts confirm the effectiveness of the drug in impaired mental processes. However, it was found that the active component significantly enhances the resistance of tissues to hypoxia, slows down the development and accelerates the restoration of cerebral edema associated with intoxication or trauma. The active substance reduces puffiness in the retina, reduces damage to the cornea, prevents the age-related decrease in the content of alpha-2-adrenergic receptors and m-cholinergic receptors, and an increase in the consumption of choline in the hippocampus.
The medicine "Memoplant" helps to improve memory, compensate for imbalances. The drug enhances the rheological (qualitative) properties of blood, improves microcirculation, increases blood flow. The tool neutralizes acid radicals, has a neuroprotective effect.
The drug "Memoplant" instruction recommends as a symptomatic treatment of dementia (Alzheimer's and vascular type), complicated by depression, impaired memory and concentration, headache, tinnitus, dizziness. The medication is prescribed for disorders in the arterial peripheral circulation, provoking pain in the limbs, paresthesia, intermittent claudication, convulsions. The medicine "Memoplant" the instruction recommends for dizziness, noise in the ears of an involutional and vascular nature.
To eliminate the symptoms of dementia, usually one or two tablets are prescribed three times a day. For disorders in the peripheral arterial circulation, a tablet is prescribed three times or two tablets twice a day.
The drug "Memoplant-Forte" in the first case is prescribed a tablet three times a day, in the second - a tablet twice a day.
The medicine is swallowed whole. The tablets should not be softened. Accepted regardless of food.
In case of dementia, the Memoplant medicine is recommended for at least eight weeks. After three months, the need and feasibility of subsequent therapy should be assessed.
In case of disturbances in the peripheral circulation, the drug is taken for at least six weeks.
As practice shows, with noise in the ears and dizziness after six to eight weeks of therapy, a subsequent improvement in the condition is unlikely.
The drug "Memoplant" instructions for use does not allow the appointment of patients under the age of twelve (due to the lack of clinical experience in use in children), as well as with individual hypersensitivity.
As medical practice shows, side effects when taking medication are noted in rare cases. The instructions include digestive system disorders, headache, itching, hyperemia, swelling and other allergic skin reactions to undesirable effects when using the Memoplant preparation. Long-term drug therapy may contribute to bleeding. However, the direct relationship of their occurrence with the use of the drug has not been established.
Due to the lack of clinical experience with the use of the drug during pregnancy and lactation, when prescribing the drug during these periods, the doctor should assess the ratio of potential risk to the fetus and the likely benefit to the mother. It is not established whether the components of the extract are excreted in breast milk.
Cases of drug overdose are not described in practice.
Before using the drug "Memoplant" you need to consult a doctor.